These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38356477)

  • 1. Longitudinal associations of apathy and regional tau in mild cognitive impairment and dementia: Findings from the Alzheimer's Disease Neuroimaging Initiative.
    Premnath PY; Locascio JJ; Mimmack KJ; Gonzalez C; Properzi MJ; Udeogu O; Rosenberg PB; Marshall GA; Gatchel JR;
    Alzheimers Dement (N Y); 2024; 10(1):e12442. PubMed ID: 38356477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional Tau Correlates of Instrumental Activities of Daily Living and Apathy in Mild Cognitive Impairment and Alzheimer's Disease Dementia.
    Marshall GA; Gatchel JR; Donovan NJ; Muniz MC; Schultz AP; Becker JA; Chhatwal JP; Hanseeuw BJ; Papp KV; Amariglio RE; Rentz DM; Sperling RA; Johnson KA
    J Alzheimers Dis; 2019; 67(2):757-768. PubMed ID: 30689584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease.
    Halawa OA; Gatchel JR; Amariglio RE; Rentz DM; Sperling RA; Johnson KA; Marshall GA;
    Alzheimers Res Ther; 2019 Jan; 11(1):14. PubMed ID: 30704519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Evolution of Financial Capacity and Cerebral Tau and Amyloid Burden in Older Adults with Normal Cognition or Mild Cognitive Impairment.
    Mimmack KJ; Sprague EH; Amariglio RE; Vannini P; Marshall GA
    J Prev Alzheimers Dis; 2024; 11(4):966-974. PubMed ID: 39044507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial Capacity and Regional Cerebral Tau in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Dementia.
    Gonzalez C; Tommasi NS; Briggs D; Properzi MJ; Amariglio RE; Marshall GA;
    J Alzheimers Dis; 2021; 79(3):1133-1142. PubMed ID: 33386806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affective symptoms and regional cerebral tau burden in early-stage Alzheimer's disease.
    Tommasi NS; Gonzalez C; Briggs D; Properzi MJ; Gatchel JR; Marshall GA;
    Int J Geriatr Psychiatry; 2021 Jul; 36(7):1050-1058. PubMed ID: 33682933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative
    Zhao Q; Liu M; Ha L; Zhou Y;
    Front Neurol; 2019; 10():486. PubMed ID: 31156534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study Partner Report of Apathy in Older Adults is Associated with AD Biomarkers: Findings from the Harvard Aging Brain Study.
    Burling JE; Katz Z; Yuan Z; Munro C; Mimmack K; Ma G; Hanseeuw BJ; Papp KV; Amariglio RE; Vannini P; Rentz DM; Quiroz YT; Johnson KA; Sperling RA; Blacker D; Marshall GA; Yang HS; Gatchel JR
    Am J Geriatr Psychiatry; 2024 Aug; 32(8):909-919. PubMed ID: 38443298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
    Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
    BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
    Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
    Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
    Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I
    J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia.
    Pontecorvo MJ; Devous MD; Kennedy I; Navitsky M; Lu M; Galante N; Salloway S; Doraiswamy PM; Southekal S; Arora AK; McGeehan A; Lim NC; Xiong H; Truocchio SP; Joshi AD; Shcherbinin S; Teske B; Fleisher AS; Mintun MA
    Brain; 2019 Jun; 142(6):1723-1735. PubMed ID: 31009046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Brain Differences Between Cognitively Impaired Patients With and Without Apathy.
    Chan NK; Gerretsen P; Chakravarty MM; Blumberger DM; Caravaggio F; Brown E; Graff-Guerrero A;
    Am J Geriatr Psychiatry; 2021 Apr; 29(4):319-332. PubMed ID: 33423870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
    Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
    JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of tau, Aβ, and brain volume of the Papez circuit with cognition in Alzheimer's disease.
    Feng Y; Laraib A; Lin X; Li Q; Zhan J; Li X
    Eur Arch Psychiatry Clin Neurosci; 2024 Jun; ():. PubMed ID: 38824476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment.
    Mundada NS; Rojas JC; Vandevrede L; Thijssen EH; Iaccarino L; Okoye OC; Shankar R; Soleimani-Meigooni DN; Lago AL; Miller BL; Teunissen CE; Heuer H; Rosen HJ; Dage JL; Jagust WJ; Rabinovici GD; Boxer AL; La Joie R
    Alzheimers Res Ther; 2023 Sep; 15(1):157. PubMed ID: 37740209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
    Ben Bouallègue F; Mariano-Goulart D; Payoux P;
    Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin: A novel marker of pre-symptomatic sporadic Alzheimer's disease.
    Quesnel MJ; Labonté A; Picard C; Bowie DC; Zetterberg H; Blennow K; Brinkmalm A; Villeneuve S; Poirier J; ;
    Alzheimers Dement; 2024 Sep; 20(9):6008-6031. PubMed ID: 39072932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
    Strom A; Iaccarino L; Edwards L; Lesman-Segev OH; Soleimani-Meigooni DN; Pham J; Baker SL; Landau SM; Jagust WJ; Miller BL; Rosen HJ; Gorno-Tempini ML; Rabinovici GD; La Joie R;
    Brain; 2022 Apr; 145(2):713-728. PubMed ID: 34373896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.